Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geron Corporation - Common Stock (NQ:GERN)

1.390 +0.120 (+9.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Geron Corporation - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Rani Therapeutics Hldgs (NASDAQ:RA... 
Via Benzinga
Geron to Present at the Stifel 2021 Virtual Healthcare Conference
From Geron Corporation
Via Business Wire
30 Stocks Moving in Wednesday's Pre-Market Session
Gainers RenovoRx, Inc. (NASDAQ: RNXT) rose 113% to $11.50 in pre-market trading. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a... 
Via Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
Geron Presents Investor Event Highlights
From Geron Corporation
Via Business Wire
Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting
From Geron Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021
Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Biophytis (NASDAQ:BPTS) shares mo... 
Via Benzinga
Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Announces Completion of Patient Enrollment in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
From Geron Corporation
Via Business Wire
Geron to Host a Virtual Investor Event in November
From Geron Corporation
Via Business Wire
15 Stocks Moving in Tuesday's Pre-Market Session
Gainers Quanterix Corporation (NASDAQ: QTRX) shares rose 17.6% to $48.55 in pre-market trading after the company announced its Simoa phospho-Tau 181 blood test has been granted... 
Via Benzinga
Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology
From Geron Corporation
Via Business Wire
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:... 
Via Benzinga
Exposures COVID-19
Geron Earnings Perspective: Return On Capital Employed
Benzinga Pro data, Geron (NASDAQ:GERN) reported Q2 sales of $107.00 thousand. Earnings fell to a loss of $28.89 million, resulting in a 1.53% decrease from last quarter. Geron... 
Via Benzinga
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Announces September Investor Conference Presentation Webcasts
From Geron Corporation
Via Business Wire
Here's What Investors Need From Geron
It could be a while before Geron has a big catalyst. 
Via The Motley Fool
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron (GERN) Q2 2021 Earnings Call Transcript
GERN earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Geron Q2 Earnings
Shares of Geron (NASDAQ:GERN) rose 2.5% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 50.00% over the past year to... 
Via Benzinga
Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023
From Geron Corporation
Via Business Wire
How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients
Via FinancialNewsMedia
Earnings Scheduled For August 16, 2021
Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to... 
Via Benzinga
30 Stocks Moving in Friday's Pre-Market Session
Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 32.9% to $0.839 in pre-market trading after the company reported better-than-expected Q2 sales. The company said it continues to... 
Via Benzinga
Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Return On Capital Employed Overview: Geron
During Q1, Geron's (NASDAQ:GERN) reported sales totaled $137.00 thousand. Despite a 22.3% in earnings, the company posted a loss of $28.45 million. Geron collected $50.00 thousand... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.